Matches in Wikidata for { <http://www.wikidata.org/entity/Q94518469> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q94518469 description "article scientifique publié en 2020" @default.
- Q94518469 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q94518469 description "scientific article published on 01 May 2020" @default.
- Q94518469 description "wetenschappelijk artikel" @default.
- Q94518469 description "наукова стаття, опублікована 1 травня 2020" @default.
- Q94518469 name "Pegylated Liposomal Doxorubicin/Oxaliplatin Chemotherapy Can Overcome Cisplatin Resistance in Spectrin αII-Overexpressing Ovarian Carcinoma" @default.
- Q94518469 name "Pegylated Liposomal Doxorubicin/Oxaliplatin Chemotherapy Can Overcome Cisplatin Resistance in Spectrin αII-Overexpressing Ovarian Carcinoma" @default.
- Q94518469 type Item @default.
- Q94518469 label "Pegylated Liposomal Doxorubicin/Oxaliplatin Chemotherapy Can Overcome Cisplatin Resistance in Spectrin αII-Overexpressing Ovarian Carcinoma" @default.
- Q94518469 label "Pegylated Liposomal Doxorubicin/Oxaliplatin Chemotherapy Can Overcome Cisplatin Resistance in Spectrin αII-Overexpressing Ovarian Carcinoma" @default.
- Q94518469 prefLabel "Pegylated Liposomal Doxorubicin/Oxaliplatin Chemotherapy Can Overcome Cisplatin Resistance in Spectrin αII-Overexpressing Ovarian Carcinoma" @default.
- Q94518469 prefLabel "Pegylated Liposomal Doxorubicin/Oxaliplatin Chemotherapy Can Overcome Cisplatin Resistance in Spectrin αII-Overexpressing Ovarian Carcinoma" @default.
- Q94518469 P1433 Q94518469-98A81992-9447-411A-B598-1455C030C659 @default.
- Q94518469 P1476 Q94518469-7F1E6DB7-F33F-4FAD-B29E-8853ED75B362 @default.
- Q94518469 P2093 Q94518469-1B5B66EA-8574-445F-9998-FBA7AFEF61D2 @default.
- Q94518469 P2093 Q94518469-CE4DAC38-52AD-4B0B-A818-BB943F054D44 @default.
- Q94518469 P2093 Q94518469-DB35A81B-902D-40C1-AAC9-B7B1D34CCF48 @default.
- Q94518469 P2093 Q94518469-E5F6E54E-A097-4D9C-8C51-D9041A701486 @default.
- Q94518469 P304 Q94518469-9FBAE9ED-C330-453C-9F1E-52CD1D9557C5 @default.
- Q94518469 P31 Q94518469-20AC136E-E068-4776-8CDA-78D916E00671 @default.
- Q94518469 P356 Q94518469-3824DBDA-A8E2-44EA-A372-54DA1ECE5417 @default.
- Q94518469 P433 Q94518469-B8C2899A-C315-4213-AA0D-C4451CAF7CEE @default.
- Q94518469 P478 Q94518469-5BD96C34-3E2B-4F51-97CE-D3C8CAE2201D @default.
- Q94518469 P50 Q94518469-855425FD-777C-48C6-83F4-F8FB2B21ADB0 @default.
- Q94518469 P577 Q94518469-2AA53929-96BE-4224-B31F-D02FF1895B7B @default.
- Q94518469 P698 Q94518469-20ACAA76-D51C-41FF-B5B0-532B43CF8091 @default.
- Q94518469 P921 Q94518469-02D84BF0-43D9-4CC1-8668-E534E492408F @default.
- Q94518469 P921 Q94518469-0BDA95BA-A7B8-4213-9FCE-E7E1B9EC77A7 @default.
- Q94518469 P921 Q94518469-825572FA-00CA-43ED-B388-5DF73F6C9D34 @default.
- Q94518469 P356 ANTICANRES.14220 @default.
- Q94518469 P698 32366394 @default.
- Q94518469 P1433 Q326290 @default.
- Q94518469 P1476 "Pegylated Liposomal Doxorubicin/Oxaliplatin Chemotherapy Can Overcome Cisplatin Resistance in Spectrin αII-Overexpressing Ovarian Carcinoma" @default.
- Q94518469 P2093 "Hiroaki Kajiyama" @default.
- Q94518469 P2093 "Kiyosumi Shibata" @default.
- Q94518469 P2093 "Osamu Maeda" @default.
- Q94518469 P2093 "Shigeo Nakamura" @default.
- Q94518469 P304 "2497-2507" @default.
- Q94518469 P31 Q13442814 @default.
- Q94518469 P356 "10.21873/ANTICANRES.14220" @default.
- Q94518469 P433 "5" @default.
- Q94518469 P478 "40" @default.
- Q94518469 P50 Q89568553 @default.
- Q94518469 P577 "2020-05-01T00:00:00Z" @default.
- Q94518469 P698 "32366394" @default.
- Q94518469 P921 Q18556145 @default.
- Q94518469 P921 Q412415 @default.
- Q94518469 P921 Q422327 @default.